Vogenx, Inc. (VOGX)
Data as of , from SEC Form 4 filings.
See up to 3 months of VOGX. The 7-day demo opens the 1M and 3M ranges and puts VOGX on your watchlist.
Start 7-day demoLatest VOGX insider trades
About Vogenx, Inc. (VOGX)
Vogenx, Inc. files with the SEC under CIK 0001903784 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector. Its offering priced on 12 August 2026 and it trades on NASDAQ.
VOGX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 6 | 615,000 | |
| Other acquisition / disposition | 4 | 47,008 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
VOGX insider transactions (Form 4)
108 Form 4 filings on record, the earliest from Aug 13, 2026, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| William Wilkison - Officer | Grant or award | Stock Option (Right to Buy) | 155,000 | $0.00 | - | |
| Kenneth John Toombs - Director | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Peter Pieraccini - Director | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| James Green - Officer | Grant or award | Stock Option (Right to Buy) | 155,000 | $0.00 | - | |
| Steven R. Delmar - Officer | Grant or award | Stock Option (Right to Buy) | 155,000 | $0.00 | - | |
| Timothy Boris - Director | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Peter Pieraccini - Director | Other | Common Stock | 42,735 | $11.70 | $500K | |
| Peter Pieraccini - Director | Other | Convertible Promissory Note | 0 | $0.00 | - | |
| Steven R. Delmar - Officer | Other | Common Stock | 4,273 | $11.70 | $50K | |
| Steven R. Delmar - Officer | Other | Convertible Promissory Note | 0 | $0.00 | - |
VOGX insider trading FAQ
What is the latest insider trade for VOGX?
Vogenx, Inc. (VOGX) had 8 insider filings in the last 90 days, with the most recent on 6 October 2026. The full record for VOGX runs to 8 Form 4 filings, the earliest from 13 August 2026. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VOGX stock?
No insider purchases of VOGX were filed in the last 90 days.
How many insiders are selling VOGX stock?
No insider sales of VOGX were filed in the last 90 days.
Where can I see VOGX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VOGX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
8The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - William Wilkison view on EDGAR
- - Kenneth John Toombs view on EDGAR
- - Peter Pieraccini view on EDGAR
- - James Green view on EDGAR
- - Steven R. Delmar view on EDGAR
- - Timothy Boris view on EDGAR
- - Peter Pieraccini view on EDGAR
- - Steven R. Delmar view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where VOGX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VOGX with a 7-day demo
- VOGX on your watchlist
- Every VOGX Form 4 filing on record
- Up to 3 months of VOGX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
